{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:30Z","timestamp":1790109930404,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03634-x","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:02:15Z","timestamp":1703080935000},"page":"541-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transition from Hashimoto thyroiditis to Graves\u2019s Disease: an unpredictable change?"],"prefix":"10.1007","volume":"84","author":[{"given":"Alberto","family":"Vassallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3398","authenticated-orcid":false,"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-550X","authenticated-orcid":false,"given":"Paola","family":"Loli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"3634_CR1","doi-asserted-by":"publisher","unstructured":"A.P. Weetman An update on the pathogenesis of Hashimoto\u2019s thyroiditis. Journal of Endocrinological Investigation, 44. Springer Science and Business Media Deutschland GmbH, pp. 883\u2013890, May 5, 2021. https:\/\/doi.org\/10.1007\/s40618-020-01477-1","DOI":"10.1007\/s40618-020-01477-1"},{"key":"3634_CR2","doi-asserted-by":"publisher","unstructured":"P. Caturegli, A. De Remigis, and N.R. Rose Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmunity Reviews, 13, 4\u20135. Elsevier, 391\u2013397, 2014. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.007","DOI":"10.1016\/j.autrev.2014.01.007"},{"key":"3634_CR3","doi-asserted-by":"crossref","unstructured":"B. Rapoport, G.D. Chazenbalk, J.C. Jaume, and S.M. Mclachlan The Thyrotropin (TSH) Receptor: Interaction with TSH and Autoantibodies*. 1998. [Online]. Available: https:\/\/academic.oup.com\/edrv\/article\/19\/6\/673\/2530796","DOI":"10.1210\/edrv.19.6.0352"},{"key":"3634_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1210\/jcem-33-4-688","volume":"33","author":"T Mori","year":"1971","unstructured":"T. Mori, J.P. Kriss, Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in graves\u2019 disease and other thyroid disorders. J. Clin. Endocrinol. Metab. 33, 688\u2013698 (1971). https:\/\/doi.org\/10.1210\/jcem-33-4-688","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3634_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1210\/jcem-46-5-734","volume":"46","author":"K Endo","year":"1978","unstructured":"K. Endo et al. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with graves\u2019 disease and hashimoto\u2019s thyroiditis. J. Clin. Endocrinol. Metab. 46, 734\u2013739 (1978). https:\/\/doi.org\/10.1210\/jcem-46-5-734","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3634_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.20945\/2359-3997000000086","volume":"62","author":"B Gonzalez-Aguilera","year":"2018","unstructured":"B. Gonzalez-Aguilera et al. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch. Endocrinol. Metab. 62(6), 609\u2013614 (2018). https:\/\/doi.org\/10.20945\/2359-3997000000086","journal-title":"Arch. Endocrinol. Metab."},{"key":"3634_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2012.0374","volume":"23","author":"SM McLachlan","year":"2013","unstructured":"S.M. McLachlan, B. Rapoport, Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23, 14\u201324 (2013). https:\/\/doi.org\/10.1089\/thy.2012.0374","journal-title":"Thyroid"},{"key":"3634_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/182176","volume":"2012","author":"N Takasu","year":"2012","unstructured":"N. Takasu, M. Matsushita, Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves\u2019 Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients. J. Thyroid Res 2012, 1\u201311 (2012). https:\/\/doi.org\/10.1155\/2012\/182176","journal-title":"J. Thyroid Res"},{"key":"3634_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0950-351X(88)80055-7","volume":"2","author":"N Amino","year":"1988","unstructured":"N. Amino, 4 Autoimmunity and hypothyroidism. Baillieres Clin. Endocrinol. Metab. 2, 591\u2013617 (1988). https:\/\/doi.org\/10.1016\/S0950-351X(88)80055-7","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"key":"3634_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1210\/jcem-64-4-718","volume":"64","author":"H Tamai","year":"1987","unstructured":"H. Tamai et al. The mechanism of spontaneous hypothyroidism in patients with graves\u2019 disease after antithyroid drug treatment. J. Clin. Endocrinol. Metab. 64, 718\u2013722 (1987). https:\/\/doi.org\/10.1210\/jcem-64-4-718","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3634_CR11","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1111\/j.1365-2265.2010.03831.x","volume":"73","author":"M Evans","year":"2010","unstructured":"M. Evans et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin. Endocrinol. (Oxf.) 73, 04\u2013412 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03831.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3634_CR12","doi-asserted-by":"crossref","unstructured":"L. Chiovato et al. Outcome of thyroid function in graves\u2019 patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage*. 1998. https:\/\/academic.oup.com\/jcem\/article\/83\/1\/40\/2865072","DOI":"10.1210\/jc.83.1.40"},{"key":"3634_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2265.1990.tb03906.x","volume":"33","author":"N Takasu","year":"1990","unstructured":"N. Takasu et al. Graves\u2019 disease following hypothyroidism due to hashimoto\u2019s disease: studies of eight cases. Clin. Endocrinol. (Oxf.) 33, 687\u2013698 (1990). https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb03906.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3634_CR14","doi-asserted-by":"publisher","first-page":"e227445","DOI":"10.1136\/bcr-2018-227445","volume":"12","author":"AR Kafrouni Gerges","year":"2019","unstructured":"A.R. Kafrouni Gerges, S.N. Clark, H. Shawa, Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles \u2013 a case series. BMJ Case Rep. 12, e227445 (2019). https:\/\/doi.org\/10.1136\/bcr-2018-227445","journal-title":"BMJ Case Rep."},{"key":"3634_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2265.1987.tb01168.x","volume":"27","author":"Z Kraiem","year":"1987","unstructured":"Z. Kraiem, N. Lahat, B. Glaser, E. Baron, O. Sadeh, M. Sheinfeld, Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis. Clin. Endocrinol. (Oxf.) 27, 409\u2013421 (1987). https:\/\/doi.org\/10.1111\/j.1365-2265.1987.tb01168.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"3634_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2169\/internalmedicine.34.247","volume":"34","author":"H Yamasaki","year":"1995","unstructured":"H. Yamasaki, K. Takeda, Y. Nakauchi, T. Suehiro, K. Hashimoto, Hypothyroidism preceding hyperthyroidism in a patient with continuously positive thyroid stimulating antibody. Intern. Med. 34(4), 247\u2013250 (1995). https:\/\/doi.org\/10.2169\/internalmedicine.34.247","journal-title":"Intern. Med."},{"key":"3634_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2249.2011.04419.x","volume":"165","author":"MG Santaguida","year":"2011","unstructured":"M.G. Santaguida et al. Increased interleukin-4-positive lymphocytes in patients with Hashimoto\u2019s thyroiditis and concurrent non-endocrine autoimmune disorders. Clin. Exp. Immunol. 165, 148\u2013154 (2011). https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04419.x","journal-title":"Clin. Exp. Immunol."},{"key":"3634_CR18","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1590\/S0100-879X2012007500168","volume":"45","author":"Q Qin","year":"2012","unstructured":"Q. Qin et al. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto\u2019s thyroiditis but not in Graves\u2019 disease. Braz. J. Med. Biol. Res. 45, 1202\u20131208 (2012). https:\/\/doi.org\/10.1590\/S0100-879X2012007500168","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"3634_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5603\/EP.2014.0008","volume":"65","author":"N Sawicka-Gutaj","year":"2014","unstructured":"N. Sawicka-Gutaj et al. Influence of cigarette smoking on thyroid gland-an update. Endokrynol. Pol. 65(1), 54\u201362 (2014). https:\/\/doi.org\/10.5603\/EP.2014.0008","journal-title":"Endokrynol. Pol."},{"key":"3634_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40618-019-01094-7","volume":"43","author":"M Rotondi","year":"2020","unstructured":"M. Rotondi et al. The clinical phenotype of Graves\u2019 disease occurring as an isolated condition or in association with other autoimmune diseases. J. Endocrinol. Invest 43, 157\u2013162 (2020). https:\/\/doi.org\/10.1007\/s40618-019-01094-7","journal-title":"J. Endocrinol. Invest"},{"key":"3634_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1871530322666220616104058","volume":"23","author":"I Ta\u015fkald\u0131ran","year":"2023","unstructured":"I. Ta\u015fkald\u0131ran, F.P. Altay, Y. Bozku\u015f, \u00d6.T. \u0130yidir, A. Nar, N.B. T\u00fct\u00fcnc\u00fc, A case report of conversion from hashimoto\u2019s thyroiditis to graves\u2019 disease in type 1 diabetic patient following the COVID-19 vaccination. Endocr. Metab. Immune Disord. Drug Targets 23, 405\u2013409 (2023). https:\/\/doi.org\/10.2174\/1871530322666220616104058","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"3634_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01067-7","volume":"22","author":"M Asano","year":"2022","unstructured":"M. Asano, T. Kenzaka, Guillain-Barr\u00e9 syndrome with transition from hashimoto\u2019s to graves\u2019 disease: a case report. BMC Endocr. Disord. 22, 157 (2022). https:\/\/doi.org\/10.1186\/s12902-022-01067-7","journal-title":"BMC Endocr. Disord."},{"key":"3634_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"HJ Lee","year":"2015","unstructured":"H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J. Autoimmun. 64, 82\u201390 (2015). https:\/\/doi.org\/10.1016\/j.jaut.2015.07.009","journal-title":"J. Autoimmun."},{"key":"3634_CR24","doi-asserted-by":"publisher","first-page":"25734","DOI":"10.3402\/jchimp.v4.25734","volume":"4","author":"W Fan","year":"2014","unstructured":"W. Fan, P. Tandon, M. Krishnamurthy, Oscillating hypothyroidism and hyperthyroidism \u2013 a case-based review. J. Comm. Hosp. Intern. Med. Perspect. 4, 25734 (2014). https:\/\/doi.org\/10.3402\/jchimp.v4.25734","journal-title":"J. Comm. Hosp. Intern. Med. Perspect."},{"key":"3634_CR25","doi-asserted-by":"publisher","unstructured":"E. Ahmad, K. Hafeez, M.F. Arshad, J. Isuga, and A. Vrettos Hypothyroidism conversion to hyperthyroidism: it\u2019s never too late. Endocrinol Diabetes Metab. Case Rep. 2018. https:\/\/doi.org\/10.1530\/EDM-18-0047","DOI":"10.1530\/EDM-18-0047"},{"key":"3634_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF03345556","volume":"29","author":"M Gola","year":"2006","unstructured":"M. Gola, M. Doga, G. Mazziotti, S. Bonadonna, A. Giustina, Development of Graves\u2019 hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto\u2019s hypothyroidism. J. Endocrinol. Invest 29, 288\u2013290 (2006). https:\/\/doi.org\/10.1007\/BF03345556","journal-title":"J. Endocrinol. Invest"},{"key":"3634_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1089\/thy.2005.15.725","volume":"15","author":"R Lu","year":"2005","unstructured":"R. Lu, K.D. Burman, J. Jonklaas, Transient graves\u2019 hyperthyroidism during pregnancy in a patient with hashimoto\u2019s hypothyroidism. Thyroid 15, 725\u2013729 (2005). https:\/\/doi.org\/10.1089\/thy.2005.15.725","journal-title":"Thyroid"},{"key":"3634_CR28","doi-asserted-by":"publisher","unstructured":"L. Bartalena, E. Piantanida, D. Gallo, A. Lai, and M.L. Tanda Epidemiology, Natural History, Risk Factors, and Prevention of Graves\u2019 Orbitopathy. Front Endocrinol (Lausanne), 11, 2020. https:\/\/doi.org\/10.3389\/fendo.2020.615993","DOI":"10.3389\/fendo.2020.615993"},{"key":"3634_CR29","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"L. Bartalena et al. The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur. J. Endocrinol 185, G43\u2013G67 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0479","journal-title":"Eur. J. Endocrinol"},{"key":"3634_CR30","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/thy.2013.0452","volume":"24","author":"T Aversa","year":"2014","unstructured":"T. Aversa, F. Lombardo, A. Corrias, M. Salerno, F. De Luca, M. Wasniewska, In young patients with turner or down syndrome, graves\u2019 disease presentation is often preceded by hashimoto\u2019s thyroiditis. Thyroid 24, 744\u2013747 (2014). https:\/\/doi.org\/10.1089\/thy.2013.0452","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03634-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:22:57Z","timestamp":1715062977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["3634"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03634-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"4 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent to participate in the study was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to partecipate"}},{"value":"Not applicable because of the complete anonymity of the data presented in the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All adult patients (age \u226518 years) affected by autoimmune thyroid disorders were included in an epidemiologic monocentric register approved by the Local Ethical Committee complying with the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}